BG
SWAV

Bellevue Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bellevue Group’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-105,786
Closed -$34.4M – 178
2024
Q1 		$34.4M Sell
105,786
-19,024
-15% -$4.67M 0.53% 60
2023
Q4 		$23.8M Sell
124,810
-129,469
-51% -$24.5M 0.36% 70
2023
Q3 		$50.6M Sell
254,279
-16,247
-6% -$3.84M 0.82% 33
2023
Q2 		$77.2M Sell
270,526
-10,850
-4% -$3.01M 1.1% 28
2023
Q1 		$61M Buy
281,376
+33,760
+14% +$6.58M 0.89% 39
2022
Q4 		$50.9M Sell
247,616
-28,516
-10% -$7.21M 0.68% 48
2022
Q3 		$76.8M Sell
276,132
-94,567
-26% -$24M 1.1% 30
2022
Q2 		$70.9M Sell
370,699
-27,878
-7% -$4.92M 1% 32
2022
Q1 		$82.6M Sell
398,577
-28,033
-7% -$4.62M 0.96% 38
2021
Q4 		$76.1M Sell
426,610
-37,637
-8% -$7.42M 0.78% 41
2021
Q3 		$95.6M Sell
464,247
-52,668
-10% -$10.3M 0.97% 36
2021
Q2 		$98.1M Buy
516,915
+32,351
+7% +$5.29M 0.96% 31
2021
Q1 		$63.1M Buy
484,564
+59,229
+14% +$7.1M 0.67% 52
2020
Q4 		$44.1M Sell
425,335
-35,918
-8% -$3.11M 0.51% 57
2020
Q3 		$35M Buy
461,253
+43,164
+10% +$2.45M 0.48% 60
2020
Q2 		$19.8M Buy
418,089
+93,428
+29% +$3.85M 0.28% 80
2020
Q1 		$10.8M Buy
324,661
+113,903
+54% +$4.52M 0.21% 84
2019
Q4 		$9.26M Buy
210,758
+109,400
+108% +$4.04M 0.15% 97
2019
Q3 		$3.03M Buy
101,358
+3,811
+4% +$162K 0.06% 121
2019
Q2 		$5.57M Sell
97,547
-2,453
-2% -$119K 0.1% 105
2019
Q1 		$3.35M Buy
+100,000
New +$3.32M 0.18% 90

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bellevue Group's SWAV Position: Q2 2024 in Review

Bellevue Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 105,786 shares — an estimated $34.4M sold.

Bellevue Group first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $98.1M in Q2 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Bellevue Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bellevue Group sold 105,786 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $34.4M.
  • Bellevue Group first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Bellevue Group's Shockwave Medical, Inc. Common Stock position peaked at $98.1M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Bellevue Group's 13F filing for Q2 2024, filed 14 Aug 2024.